ISRG — the data doesn't flag an extreme on any single dimension (trailing P/E 58.5). Balanced setups in our screening have historically rewarded sizing discipline over tactical entry work for large-cap Healthcare names.
Intuitive Surgical, Inc. ranks at the bottom of today's Healthcare screening at 1.0/10. At $482.22, price is 3.8% below the 200-day average, with no meaningful structural support in the composite read.
Normal 20-day ATR range on ISRG (beta 1.68) meets a bearish regime. Premium levels are workable; the context around them is not, as stocks below their 200-day average have historically shown a tendency to continue lower before stabilizing.
ISRG's price momentum is accelerating — the rate of change is increasing rather than flattening. At $482.22, 3.8% below the 200-day average, the tape shows the kind of impulse that has historically persisted for multiple weeks in the Healthcare sector.
No extreme flags register on ISRG at the current configuration. Earnings is 85 days out (2026-07-21). The balanced setup shifts the risk-management weight from timing to position sizing.
Cash-secured puts require holding cash equal to strike × 100 shares as collateral. Strike defaults to ~5% OTM, snapped to typical exchange increments. Premium defaults to ~2% of strike — adjust to your real expected fill. Annualized ROC = (premium ÷ collateral) × (365 ÷ DTE). CSP risk is single-name concentration: experienced put-sellers typically diversify across 4–6 underlyings rather than committing the whole account to one ticker. Continuous-rolling projections assume capital can be re-deployed after each expiration and that comparable premiums remain available — actual results vary with market conditions, assignments, and rolls.